Acrocallosal Syndrome Therapeutics MarketThe global Acrocallosal Therapeutics Market is currently valued at USD 147.9 million ...

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

Sekera: Rogers is a 5-star-rated stock, trades at a 31% discount to fair value and a 3.8% yield. The company we rate with a narrow economic moat based on its efficient scale and cost advantages and ...

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...